🚀 Mission View
A sharper perspective on this week's issue that matters at the intersection of health and AI.
Stanford researchers recenly crossed a milestone: using AI to design synthetic viruses that actually work in the lab. The experiment was limited to bacteriophages that can’t infect humans, but the implications are enormous — showing how generative AI can now “write” genetic code as easily as it writes text. On one hand, this could be harnessed to fight antibiotic-resistant infections. On the other, it collapses the timeline between design and disaster, raising profound biosecurity risks.
That’s why governance matters. Just this week, California passed the nation’s first AI safety law, requiring developers to disclose their safety protocols and report incidents — a move that could set the standard for other states, and perhaps nationally. The Stanford breakthrough makes clear why this is not an abstract policy debate: the same tools that can cure disease could also be misused, and oversight frameworks will determine which side of that ledger wins out.
So what? For mission-driven health organizations, the question is how to engage. These advances will shape the operating environment for years to come. Leaders don’t need to be biosecurity experts, but they do need to stay attuned to where policy is headed — and start building the governance and trust structures that will let them apply AI’s promise safely and credibly.
🛜 Field Signals
A quick hit on this week’s key policy shifts and industry trends.
This week, the FDA published a request for information asking patients, doctors, tech companies, and others for feedback on how medical AI performance should be measured and evaluated.
In her substack blog, Halle Tecco ask whether you would trust AI write you a prescription. Also, be sure to tap on the link to her podcast with Reed Jobs from Yosemite. It’s a great discussion on the future of cancer research and how synthetic trial data could lead to new efficiencies and breakthroughs.
Speaking of Cancer research. President Trump’s announced a $50M investment to apply AI to pediatric cancer research, doubling the budget of an existing childhood cancer data initiative. Officials say the funding will support AI models to improve clinical trials, sharpen diagnoses, and tailor treatments. The move underscores Washington’s growing embrace of AI — even as the administration cuts biomedical research more broadly.
OpenAI is turning ChatGPT into a storefront. Its new Instant Checkout feature (built with Stripe) lets users buy directly from Etsy — with Shopify next. If AI becomes a trusted interface for transactions, it’s not a stretch to imagine patients ordering prescriptions, supplies, or services the same way. Mission-driven health orgs should be asking: are we ready for AI as a front door, not just a search tool?
A new Health Affairs piece argues that CMS’s push toward more downside risk will falter without better digital quality measures — and that AI could help by closing care gaps, supporting population health, and easing clinician burden.
🛠️ Practical Edge
Actionable tips and tools to help leaders strengthen capacity and apply AI in their work.
OpenAI just launched Pulse, a new feature that delivers a personalized research briefing each morning based on your needs. Think of it as an AI research assistant working overnight so you can start the day focused on decisions, not digging. Here’s a pretty handy breakdown on what it does, and doesn’t do.
Microsoft just rolled out Agent Mode, an AI “expert” that can build spreadsheets, analyze data, and draft polished documents while you guide. It puts budgeting, reporting, and program analysis within reach for non-technical staff, freeing leaders to focus on decisions, not formulas. The caveat: human oversight is still essential for quality control.
🌅 On the Horizon
A quick look at the developments and events expected to shape the weeks ahead.
Sep. 24-Oct. 15: The National Quality Forum (NQF), an affiliate of Joint Commission, is seeking comments from the public on a draft of its upcoming report on the use of artificial intelligence (AI) methods in healthcare quality measurement.
Sep. 29: LinkedIn News is hosting a webinar on “Build AI Habits That Set You Apart”, with Connor Grenna - CEO, AI Mindset and Chief AI Architect, NYU Stern School of Business. Register here.
Oct. 16: Crowell & Moring is hosting a webinar on the fast-evolving AI regulatory landscape, from the White House’s “America’s AI Action Plan” to a wave of new state laws in healthcare, labor, and privacy. The session will unpack compliance risks, federal–state tensions, and what organizations should expect next. Register here.
Oct. 21-22: TedAI San Francisco.
Dec. 8-9: Fortune Brainstorm AI San Francisco. Apply to attend here.
⌚️ Closing Time
A parting thought on what health leaders need to be focused on.
Pew finds only about 1 in 10 Americans regularly get news from AI chatbots — and many of them don’t trust what they see. At the same time, the Wall Street Journal reports that patients are increasingly turning to home tests, devices, and chatbots to manage their own care amid long waits and rising chronic disease. For health leaders, these two trends collide: people are relying more on self-care tools. As AI continues to skyrocket across industries - including health - it could be a useful tool in self-care, yet people remain skeptical of AI’s accuracy (rightfully so). The reality is that humans will still need to be in the loop - clinicians to validate, and patients to sharpen their ability to discern what’s credible. The future of health information isn’t just about smarter AI; it’s about more engaged, better-equipped patients.
Till next time,
